Bell Biosystems, Inc. — Form D
Bell Biosystems, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-08. The offering totals $3.1M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-01-08
- Form: D
- Accession: 0001550379-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.1M
- Amount sold: $2.1M
- Remaining: $1.0M
- Investors: 20
- Date of first sale: 2013-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209484
Issuer
- Name: Bell Biosystems, Inc.
- CIK: 0001550379
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: (703) 343-6477
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Daniel B Bell | Director | San Francisco, CA |
| Daniel B Bell | Executive Officer | San Francisco, CA |
| Una B Ryan | Director | San Francisco, CA |
| Bell, III B Caleb | Director | San Francisco, CA |
| Bell, III B Caleb | Executive Officer | San Francisco, CA |
| Stuart B Berman | Director | San Francisco, CA |
| Christian B Olgaard | Director | San Francisco, CA |
| Gil B Van Bokkelen | Director | San Francisco, CA |
| Bell B Caleb | Director | Sunnyvale, CA |
| Bell B Caleb | Executive Officer | Sunnyvale, CA |
| Caleb B Bell | Director | Sunnyvale, CA |
| Caleb B Bell | Executive Officer | Sunnyvale, CA |
Other filings by this issuer (3)
More